article thumbnail

Illingworth: mobile nursing can reduce trial patient burden

Outsourcing Pharma

A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going.

Nurses 97
article thumbnail

How Can You Manage the Complexity of Early Phase Clinical Development?

XTalks

Oren Cohen, MD, FIDSA CMO & President of Clinical Pharmacology Fortrea Fortrea is a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, market access solutions and other enabling services. They are unique and require specific expertise.” FIH studies involve a lot of risk.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Benefits of Working for a Rapidly Growing Global Clinical Research Organization (CRO) like Medpace

XTalks

A clinical research organization (CRO) is a company that delivers outsourced services to plan, manage and execute clinical trials for biotechnology, pharmaceutical, and medical device companies. Medpace has various opportunities for nurses and other healthcare professionals.

article thumbnail

Finding the right partners key to decentralized trials: Illingworth

Outsourcing Pharma

A leader from the mobile research nursing specialist offers advice on what to look for in a service provider, and why finding the right one is vital.

Nurses 59
article thumbnail

?5 Things You Need to Know from Our Recent Gene Therapy Webinar

Worldwide Clinical Trials

We’ve also seen a decrease in available research nurses, as they have had to be reassigned to COVID patients. It really is—there has been a 10x increase in cell and gene therapies in the clinical development pipeline since 2012. Fewer staff creates many problems, including less bandwidth to meet for reviews and approvals.

article thumbnail

Unlocking the potential in rare disease research with decentralised trials

pharmaphorum

Clearly, face-to-face visits will still be necessary, but through a decentralised approach these can be limited and balanced with home visits from nurses or by engaging local clinics and hospitals so some appointments can be conducted at the patient’s regular doctor’s office.

Trials 133
article thumbnail

World Parkinson’s Day 2023 and Promising Parkinson’s Disease Treatments

XTalks

ND0612 is currently in Phase III of clinical development and is supported by four years of safety data. Promising Treatments for Parkinson’s Disease Although there is currently no cure for Parkinson’s disease, there are combinations of medications, surgical treatments and other therapies that can relieve symptoms in patients.